Table of Content

1 Heparin Injection Market Overview
1.1 Product Overview and Scope of Heparin Injection
1.2 Heparin Injection Segment by Type
1.2.1 Global Heparin Injection Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 1,000 USP/mL
1.2.3 5,000 USP/mL
1.2.4 10,000 USP/mL
1.2.5 20,000 USP/mL
1.3 Heparin Injection Segment by Application
1.3.1 Heparin Injection Sales Comparison by Application: (2021-2027)
1.3.2 Thrombosis,
1.3.3 Pulmonary Embolism
1.3.4 Hemodialysis
1.3.5 Others
1.4 Global Heparin Injection Market Size Estimates and Forecasts
1.4.1 Global Heparin Injection Revenue 2016-2027
1.4.2 Global Heparin Injection Sales 2016-2027
1.4.3 Heparin Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Heparin Injection Market Competition by Manufacturers
2.1 Global Heparin Injection Sales Market Share by Manufacturers (2016-2021)
2.2 Global Heparin Injection Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Heparin Injection Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Heparin Injection Manufacturing Sites, Area Served, Product Type
2.5 Heparin Injection Market Competitive Situation and Trends
2.5.1 Heparin Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Heparin Injection Players Market Share by Revenue
2.5.3 Global Heparin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Heparin Injection Retrospective Market Scenario by Region
3.1 Global Heparin Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Heparin Injection Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Heparin Injection Market Facts & Figures by Country
3.3.1 North America Heparin Injection Sales by Country
3.3.2 North America Heparin Injection Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Heparin Injection Market Facts & Figures by Country
3.4.1 Europe Heparin Injection Sales by Country
3.4.2 Europe Heparin Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Heparin Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Heparin Injection Sales by Region
3.5.2 Asia Pacific Heparin Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Heparin Injection Market Facts & Figures by Country
3.6.1 Latin America Heparin Injection Sales by Country
3.6.2 Latin America Heparin Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Heparin Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Heparin Injection Sales by Country
3.7.2 Middle East and Africa Heparin Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Heparin Injection Historic Market Analysis by Type
4.1 Global Heparin Injection Sales Market Share by Type (2016-2021)
4.2 Global Heparin Injection Revenue Market Share by Type (2016-2021)
4.3 Global Heparin Injection Price by Type (2016-2021)

5 Global Heparin Injection Historic Market Analysis by Application
5.1 Global Heparin Injection Sales Market Share by Application (2016-2021)
5.2 Global Heparin Injection Revenue Market Share by Application (2016-2021)
5.3 Global Heparin Injection Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Corporation Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Heparin Injection Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Inc Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Wellona Pharma
6.2.1 Wellona Pharma Corporation Information
6.2.2 Wellona Pharma Description and Business Overview
6.2.3 Wellona Pharma Heparin Injection Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Wellona Pharma Product Portfolio
6.2.5 Wellona Pharma Recent Developments/Updates
6.3 B. Braun
6.3.1 B. Braun Corporation Information
6.3.2 B. Braun Description and Business Overview
6.3.3 B. Braun Heparin Injection Sales, Revenue and Gross Margin (2016-2021)
6.3.4 B. Braun Product Portfolio
6.3.5 B. Braun Recent Developments/Updates
6.4 Gland Pharma Limited
6.4.1 Gland Pharma Limited Corporation Information
6.4.2 Gland Pharma Limited Description and Business Overview
6.4.3 Gland Pharma Limited Heparin Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Gland Pharma Limited Product Portfolio
6.4.5 Gland Pharma Limited Recent Developments/Updates
6.5 Sagent Pharmaceuticals, Inc
6.5.1 Sagent Pharmaceuticals, Inc Corporation Information
6.5.2 Sagent Pharmaceuticals, Inc Description and Business Overview
6.5.3 Sagent Pharmaceuticals, Inc Heparin Injection Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sagent Pharmaceuticals, Inc Product Portfolio
6.5.5 Sagent Pharmaceuticals, Inc Recent Developments/Updates
6.6 Stanex
6.6.1 Stanex Corporation Information
6.6.2 Stanex Description and Business Overview
6.6.3 Stanex Heparin Injection Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Stanex Product Portfolio
6.6.5 Stanex Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Heparin Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Rewine Pharmaceutical
6.8.1 Rewine Pharmaceutical Corporation Information
6.8.2 Rewine Pharmaceutical Description and Business Overview
6.8.3 Rewine Pharmaceutical Heparin Injection Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Rewine Pharmaceutical Product Portfolio
6.8.5 Rewine Pharmaceutical Recent Developments/Updates
6.9 Shenzhen Techdow Pharmaceutical Co., Ltd
6.9.1 Shenzhen Techdow Pharmaceutical Co., Ltd Corporation Information
6.9.2 Shenzhen Techdow Pharmaceutical Co., Ltd Description and Business Overview
6.9.3 Shenzhen Techdow Pharmaceutical Co., Ltd Heparin Injection Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Shenzhen Techdow Pharmaceutical Co., Ltd Product Portfolio
6.9.5 Shenzhen Techdow Pharmaceutical Co., Ltd Recent Developments/Updates

7 Heparin Injection Manufacturing Cost Analysis
7.1 Heparin Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Heparin Injection
7.4 Heparin Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Heparin Injection Distributors List
8.3 Heparin Injection Customers

9 Heparin Injection Market Dynamics
9.1 Heparin Injection Industry Trends
9.2 Heparin Injection Growth Drivers
9.3 Heparin Injection Market Challenges
9.4 Heparin Injection Market Restraints

10 Global Market Forecast
10.1 Heparin Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Heparin Injection by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Heparin Injection by Type (2022-2027)
10.2 Heparin Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Heparin Injection by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Heparin Injection by Application (2022-2027)
10.3 Heparin Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Heparin Injection by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Heparin Injection by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Heparin Injection Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Heparin Injection Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Heparin Injection Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Heparin Injection Covered in This Study
Table 5. Global Heparin Injection Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Heparin Injection Sales Share by Manufacturers (2016-2021)
Table 7. Global Heparin Injection Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Heparin Injection Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Heparin Injection Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Heparin Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Heparin Injection Product Type
Table 12. Global Heparin Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Heparin Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin Injection as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Heparin Injection Sales by Region (2016-2021) & (K Units)
Table 16. Global Heparin Injection Sales Market Share by Region (2016-2021)
Table 17. Global Heparin Injection Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Heparin Injection Sales by Country (2016-2021) & (K Units)
Table 19. North America Heparin Injection Sales Market Share by Country (2016-2021)
Table 20. North America Heparin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Heparin Injection Revenue Market Share by Country (2016-2021)
Table 22. Europe Heparin Injection Sales by Country (2016-2021) & (K Units)
Table 23. Europe Heparin Injection Sales Market Share by Country (2016-2021)
Table 24. Europe Heparin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Heparin Injection Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Heparin Injection Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Heparin Injection Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Heparin Injection Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Heparin Injection Revenue Market Share by Region (2016-2021)
Table 30. Latin America Heparin Injection Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Heparin Injection Sales Market Share by Country (2016-2021)
Table 32. Latin America Heparin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Heparin Injection Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Heparin Injection Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Heparin Injection Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Heparin Injection Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Heparin Injection Revenue Market Share by Country (2016-2021)
Table 38. Global Heparin Injection Sales (K Units) by Type (2016-2021)
Table 39. Global Heparin Injection Sales Market Share by Type (2016-2021)
Table 40. Global Heparin Injection Revenue (Million US$) by Type (2016-2021)
Table 41. Global Heparin Injection Revenue Share by Type (2016-2021)
Table 42. Global Heparin Injection Price (USD/Unit) by Type (2016-2021)
Table 43. Global Heparin Injection Sales (K Units) by Application (2016-2021)
Table 44. Global Heparin Injection Sales Market Share by Application (2016-2021)
Table 45. Global Heparin Injection Revenue (Million US$) by Application (2016-2021)
Table 46. Global Heparin Injection Revenue Share by Application (2016-2021)
Table 47. Global Heparin Injection Price (USD/Unit) by Application (2016-2021)
Table 48. Pfizer Inc Corporation Information
Table 49. Pfizer Inc Description and Business Overview
Table 50. Pfizer Inc Heparin Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Pfizer Inc Heparin Injection Product
Table 52. Pfizer Inc Recent Developments/Updates
Table 53. Wellona Pharma Corporation Information
Table 54. Wellona Pharma Description and Business Overview
Table 55. Wellona Pharma Heparin Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Wellona Pharma Heparin Injection Product
Table 57. Wellona Pharma Recent Developments/Updates
Table 58. B. Braun Corporation Information
Table 59. B. Braun Description and Business Overview
Table 60. B. Braun Heparin Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. B. Braun Heparin Injection Product
Table 62. B. Braun Recent Developments/Updates
Table 63. Gland Pharma Limited Corporation Information
Table 64. Gland Pharma Limited Description and Business Overview
Table 65. Gland Pharma Limited Heparin Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Gland Pharma Limited Heparin Injection Product
Table 67. Gland Pharma Limited Recent Developments/Updates
Table 68. Sagent Pharmaceuticals, Inc Corporation Information
Table 69. Sagent Pharmaceuticals, Inc Description and Business Overview
Table 70. Sagent Pharmaceuticals, Inc Heparin Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Sagent Pharmaceuticals, Inc Heparin Injection Product
Table 72. Sagent Pharmaceuticals, Inc Recent Developments/Updates
Table 73. Stanex Corporation Information
Table 74. Stanex Description and Business Overview
Table 75. Stanex Heparin Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Stanex Heparin Injection Product
Table 77. Stanex Recent Developments/Updates
Table 78. Mylan Corporation Information
Table 79. Mylan Description and Business Overview
Table 80. Mylan Heparin Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Mylan Heparin Injection Product
Table 82. Mylan Recent Developments/Updates
Table 83. Rewine Pharmaceutical Corporation Information
Table 84. Rewine Pharmaceutical Description and Business Overview
Table 85. Rewine Pharmaceutical Heparin Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Rewine Pharmaceutical Heparin Injection Product
Table 87. Rewine Pharmaceutical Recent Developments/Updates
Table 88. Shenzhen Techdow Pharmaceutical Co., Ltd Corporation Information
Table 89. Shenzhen Techdow Pharmaceutical Co., Ltd Description and Business Overview
Table 90. Shenzhen Techdow Pharmaceutical Co., Ltd Heparin Injection Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Shenzhen Techdow Pharmaceutical Co., Ltd Heparin Injection Product
Table 92. Shenzhen Techdow Pharmaceutical Co., Ltd Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Heparin Injection Distributors List
Table 96. Heparin Injection Customers List
Table 97. Heparin Injection Market Trends
Table 98. Heparin Injection Growth Drivers
Table 99. Heparin Injection Market Restraints
Table 100. Global Heparin Injection Sales Forecast by Type (2022-2027) & (K Units)
Table 101. Global Heparin Injection Sales Market Share Forecast by Type (2022-2027)
Table 102. Global Heparin Injection Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global Heparin Injection Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global Heparin Injection Sales Forecast by Application (2022-2027) & (K Units)
Table 105. Global Heparin Injection Sales Market Share Forecast by Application (2022-2027)
Table 106. Global Heparin Injection Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global Heparin Injection Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global Heparin Injection Sales Forecast by Region (2022-2027) & (K Units)
Table 109. Global Heparin Injection Sales Market Share Forecast by Region (2022-2027)
Table 110. Global Heparin Injection Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global Heparin Injection Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Heparin Injection
Figure 2. Global Heparin Injection Market Share by Type in 2020 & 2027
Figure 3. 1,000 USP/mL Product Picture
Figure 4. 5,000 USP/mL Product Picture
Figure 5. 10,000 USP/mL Product Picture
Figure 6. 20,000 USP/mL Product Picture
Figure 7. Global Heparin Injection Market Share by Application in 2020 & 2027
Figure 8. Thrombosis,
Figure 9. Pulmonary Embolism
Figure 10. Hemodialysis
Figure 11. Others
Figure 12. Global Heparin Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Heparin Injection Market Size 2016-2027 (US$ Million)
Figure 14. Global Heparin Injection Sales 2016-2027 (K Units)
Figure 15. Global Heparin Injection Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Heparin Injection Sales Share by Manufacturers in 2020
Figure 17. Global Heparin Injection Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Heparin Injection Players: Market Share by Revenue in 2020
Figure 19. Heparin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Heparin Injection Sales Market Share by Region (2016-2021)
Figure 21. Global Heparin Injection Sales Market Share by Region in 2020
Figure 22. Global Heparin Injection Revenue Market Share by Region (2016-2021)
Figure 23. Global Heparin Injection Revenue Market Share by Region in 2020
Figure 24. U.S. Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Heparin Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Heparin Injection by Type (2016-2021)
Figure 49. Sales Market Share of Heparin Injection by Application (2016-2021)
Figure 50. Sales Market Share of Heparin Injection by Application in 2020
Figure 51. Revenue Share of Heparin Injection by Application (2016-2021)
Figure 52. Revenue Share of Heparin Injection by Application in 2020
Figure 53. Manufacturing Cost Structure of Heparin Injection
Figure 54. Manufacturing Process Analysis of Heparin Injection
Figure 55. Heparin Injection Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed